Literature DB >> 19091859

Vacuolar protein sorting pathway contributes to the release of Marburg virus.

Larissa Kolesnikova1, Thomas Strecker, Eiji Morita, Florian Zielecki, Eva Mittler, Colin Crump, Stephan Becker.   

Abstract

VP40, the major matrix protein of Marburg virus, is the main driving force for viral budding. Additionally, cellular factors are likely to play an important role in the release of progeny virus. In the present study, we characterized the influence of the vacuolar protein sorting (VPS) pathway on the release of virus-like particles (VLPs), which are induced by Marburg virus VP40. In the supernatants of HEK 293 cells expressing VP40, different populations of VLPs with either a vesicular or a filamentous morphology were detected. While the filaments were almost completely composed of VP40, the vesicular particles additionally contained considerable amounts of cellular proteins. In contrast to that in the vesicles, the VP40 in the filaments was regularly organized, probably inducing the elimination of cellular proteins from the released VLPs. Vesicular particles were observed in the supernatants of cells even in the absence of VP40. Mutation of the late-domain motif in VP40 resulted in reduced release of filamentous particles, and likewise, inhibition of the VPS pathway by expression of a dominant-negative (DN) form of VPS4 inhibited the release of filamentous particles. In contrast, the release of vesicular particles did not respond significantly to the expression of DN VPS4. Like the budding of VLPs, the budding of Marburg virus particles was partially inhibited by the expression of DN VPS4. While the release of VLPs from VP40-expressing cells is a valuable tool with which to investigate the budding of Marburg virus particles, it is important to separate filamentous VLPs from vesicular particles, which contain many cellular proteins and use a different budding mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19091859      PMCID: PMC2643735          DOI: 10.1128/JVI.02184-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  ATPase-defective mammalian VPS4 localizes to aberrant endosomes and impairs cholesterol trafficking.

Authors:  N Bishop; P Woodman
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 2.  Protection against filovirus infection: virus-like particle vaccines.

Authors:  Chinglai Yang; Ling Ye; Richard W Compans
Journal:  Expert Rev Vaccines       Date:  2008-04       Impact factor: 5.217

3.  The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function.

Authors:  M Babst; B Wendland; E J Estepa; S D Emr
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

4.  Endosomal transport function in yeast requires a novel AAA-type ATPase, Vps4p.

Authors:  M Babst; T K Sato; L M Banta; S D Emr
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

5.  Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures.

Authors:  E C Coronel; K G Murti; T Takimoto; A Portner
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations.

Authors:  P Gluschankof; I Mondor; H R Gelderblom; Q J Sattentau
Journal:  Virology       Date:  1997-03-31       Impact factor: 3.616

7.  Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.

Authors:  J W Bess; R J Gorelick; W J Bosche; L E Henderson; L O Arthur
Journal:  Virology       Date:  1997-03-31       Impact factor: 3.616

8.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease.

Authors:  M Huang; J M Orenstein; M A Martin; E O Freed
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 9.  Mechanisms for enveloped virus budding: can some viruses do without an ESCRT?

Authors:  Benjamin J Chen; Robert A Lamb
Journal:  Virology       Date:  2007-12-11       Impact factor: 3.616

10.  The ESCRT machinery is not required for human cytomegalovirus envelopment.

Authors:  Alberto Fraile-Ramos; Annegret Pelchen-Matthews; Cristina Risco; María T Rejas; Vincent C Emery; Aycan F Hassan-Walker; Mariano Esteban; Mark Marsh
Journal:  Cell Microbiol       Date:  2007-08-29       Impact factor: 3.715

View more
  19 in total

1.  Cellular VPS4 is required for efficient entry and egress of budded virions of Autographa californica multiple nucleopolyhedrovirus.

Authors:  Zhaofei Li; Gary W Blissard
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Viral and host proteins that modulate filovirus budding.

Authors:  Yuliang Liu; Ronald N Harty
Journal:  Future Virol       Date:  2010-07-01       Impact factor: 1.831

3.  Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.

Authors:  Kevin B Spurgers; Tim Alefantis; Brian D Peyser; Gordon T Ruthel; Alison A Bergeron; Julie A Costantino; Sven Enterlein; Krishna P Kota; R C Dutch Boltz; M Javad Aman; Vito G Delvecchio; Sina Bavari
Journal:  Mol Cell Proteomics       Date:  2010-08-11       Impact factor: 5.911

4.  Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles.

Authors:  Olga Dolnik; Larissa Kolesnikova; Lea Stevermann; Stephan Becker
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 5.  Conformational plasticity of the Ebola virus matrix protein.

Authors:  Jens Radzimanowski; Gregory Effantin; Winfried Weissenhorn
Journal:  Protein Sci       Date:  2014-09-04       Impact factor: 6.725

6.  ALIX Rescues Budding of a Double PTAP/PPEY L-Domain Deletion Mutant of Ebola VP40: A Role for ALIX in Ebola Virus Egress.

Authors:  Ziying Han; Jonathan J Madara; Yuliang Liu; Wenbo Liu; Gordon Ruthel; Bruce D Freedman; Ronald N Harty
Journal:  J Infect Dis       Date:  2015-03-18       Impact factor: 5.226

7.  Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particles.

Authors:  Larissa Spiegelberg; Victoria Wahl-Jensen; Larissa Kolesnikova; Heinz Feldmann; Stephan Becker; Thomas Hoenen
Journal:  J Gen Virol       Date:  2011-09-07       Impact factor: 3.891

8.  Marburg virus VP40 antagonizes interferon signaling in a species-specific manner.

Authors:  Charalampos Valmas; Christopher F Basler
Journal:  J Virol       Date:  2011-02-16       Impact factor: 5.103

9.  A Single Amino Acid Change in the Marburg Virus Matrix Protein VP40 Provides a Replicative Advantage in a Species-Specific Manner.

Authors:  Alexander Koehler; Larissa Kolesnikova; Ulla Welzel; Gordian Schudt; Astrid Herwig; Stephan Becker
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103

10.  Marburg virus evades interferon responses by a mechanism distinct from ebola virus.

Authors:  Charalampos Valmas; Melanie N Grosch; Michael Schümann; Judith Olejnik; Osvaldo Martinez; Sonja M Best; Verena Krähling; Christopher F Basler; Elke Mühlberger
Journal:  PLoS Pathog       Date:  2010-01-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.